1. Membrane expression of the death ligand trail receptors DR4 and DR5 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer. (July 2013) Authors: Gottwald, L.; Szwalski, J.; Piekarski, J.; Pasz-Walczak, G.; Kubiak, R.; Spych, M.; Suzin, J.; Tyliński, W.; Sęk, P.; Jeziorski, A. Journal: Journal of obstetrics and gynaecology Issue: Volume 33:Number 5(2013) Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Membrane expression of trail receptors DcR1 and DcR2 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer. (May 2014) Authors: Gottwald, L.; Pasz-Walczak, G.; Piekarski, J.; Szwalski, J.; Kubiak, R.; Spych, M.; Suzin, J.; Tyliński, W.; Sęk, P.; Jeziorski, A. Journal: Journal of obstetrics and gynaecology Issue: Volume 34:Number 4(2014) Page Start: 346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-0744: LBP is predictive for long-term cardiac complications in breast cancer patients. (April 2018) Authors: Chalubinska-Fendler, J.; Graczyk, Ł.; Piotrowski, G.; Tomasik, B.; Wyka, K.; Spych, M.; Papis-Ubych, A.; Fendler, W.; Fijuth, J. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗